EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India

Thomas Alexander, Jagdish S Hiremath, Jitendra P S Swahney, Subhash Chandra, Peeyush Jain, Praveen Chandra, Nakul Sinha, T Sashikanth, Yugandhar Bachhu, Anil Balachandran, Pathiyil Balagopalan Jayagopal, T Govindan Unni und 13 weitere

The Journal of Clinical Hypertension · 2025

DOI: 10.1111/jch.14963 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Thomas Alexander und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Cardiology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Practice Patterns, Physicians', Drug Prescriptions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eris Life Sciences Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated initial antihypertensive drug prescription patterns in Indian healthcare settings. An observational, cross‐sectional, prospective prescription registry analyzed prescriptions for 4723 newly diagnosed hypertension patients. Additionally, it investigated the extent to which physicians adhered to either European or Indian hypertension guidelines. Angiotensin receptor blockers (ARBs) were the most commonly prescribed drugs, given to 79% of patients, followed by calcium channel blockers (CCBs) at 55%. Diuretics and beta‐blockers (BBs) were prescribed to 27% and 17% of patients, respectively. Monotherapy was administered to 35% of patients, while combination therapies were more prevalent, with dual therapy at 51% and regimens involving three or more drugs prescribed to 14%. Among multi‐drug treatments ( n = 3082, 65%), 98% received fixed‐dose combination tablets. The most common combinations were ARB + CCB (26%), ARB + diuretic (12%), and ARB + CCB + diuretic (8%). Key predictors for an increasing number of prescribed drugs included statin use/dyslipidemia, age, blood pressure level, and diabetes. Non‐adherence to hypertension guidelines was evident as 1364 patients classified from moderate to very high risk received monotherapy. Of these, 496 patients had grade 2 or 3 hypertension. Additionally, 88 patients received the undesirable combination of ACEi + ARB, and 267 (15.9%) type 2 diabetes mellitus (T2DM) patients did not receive RAS‐blockers (146 on monotherapy). The findings reveal a trend toward utilizing ARBs, CCBs, and combination tablets, indicating improved adherence to guidelines. However, a significant number of patients did not receive appropriate treatment, highlighting areas for improvement in prescription practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionAntihypertensive AgentsPractice Patterns, Physicians'Drug PrescriptionsHumansIndiaFemaleMaleMiddle AgedCross-Sectional StudiesCalcium Channel BlockersAngiotensin Receptor AntagonistsAgedDiureticsProspective StudiesAdrenergic beta-AntagonistsDrug Therapy, CombinationAdultGuideline AdherencePractice Guidelines as Topic

Stichwörter der Autor:innen

antihypertensive therapyclinical management of high blood pressure (HBP)clinical pharmacologycombination therapyepidemiology

Substanzen

Antihypertensive AgentsCalcium Channel BlockersAngiotensin Receptor AntagonistsDiureticsAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Interventional Cardiology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India.
  • Department of Interventional Cardiology, Ruby Hall Clinic, Pune, Maharashtra, India.
  • Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, India.
  • Department of Interventional Cardiology - Cardiology & Structural Heart Disease, Blk-Max Super Speciality Hospital, New Delhi, India.
  • Department of Preventive Cardiology, Fortis Hospital Delhi, New Delhi, India.
  • Department of Interventional Cardiology, Cardiac Care, Medanta Medicity, Gurgaon, India.

ORCID-Profile: Willem J Verberk

Förderung

  • Eris Life Sciences Ltd

Zitieren

APA

Alexander, T., Hiremath, J. S., Swahney, J. P. S., Chandra, S., Jain, P., Chandra, P., Sinha, N., Sashikanth, T., Bachhu, Y., Balachandran, A., Jayagopal, P. B., Unni, T. G., Nair, T., Kannan, K., Prabhakar, D., Chenniappan, M., Mahajan, A. U., Karnik, R. D., Ponde, C. K., …, & Verberk, W. J. (2025). Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14963

Vancouver

Alexander T, Hiremath JS, Swahney JPS, Chandra S, Jain P, Chandra P, et al. Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.14963

BibTeX
@article{Alexander2025,
  author = {Alexander, Thomas and Hiremath, Jagdish S and Swahney, Jitendra P S and Chandra, Subhash and Jain, Peeyush and Chandra, Praveen and Sinha, Nakul and Sashikanth, T and Bachhu, Yugandhar and Balachandran, Anil and Jayagopal, Pathiyil Balagopalan and Unni, T Govindan and Nair, Tiny and Kannan, Kumaresan and Prabhakar, Dorairaj and Chenniappan, M and Mahajan, Ajay U and Karnik, Rajiv D and Ponde, Chandrashekhar K and Advani, Prashant and Khan, Idris Ahmed and Goyal, Brij Mohan and Vaidyanathan, P R and Prajapati, Hiren and Verberk, Willem J},
  title = {Identifying Drug Prescription in Newly Diagnosed Hypertension Patients in India},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  doi = {10.1111/jch.14963}
}
Kostenlos starten →